Cargando…

Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials

BACKGROUND: All currently available SARS-CoV-2 vaccines are administered by intramuscular injection. We aimed to evaluate the safety and immunogenicity of a live-attenuated influenza virus vector-based SARS-CoV-2 vaccine (dNS1-RBD) administered by intranasal spray in healthy adults. METHODS: We did...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Fengcai, Zhuang, Chunlan, Chu, Kai, Zhang, Liang, Zhao, Hui, Huang, Shoujie, Su, Yingying, Lin, Hongyan, Yang, Changlin, Jiang, Hanmin, Zang, Xia, Liu, Donglin, Pan, Hongxing, Hu, Yuemei, Liu, Xiaohui, Chen, Qi, Song, Qiaoqiao, Quan, Jiali, Huang, Zehong, Zhong, Guohua, Chen, Junyu, Han, Jinle, Sun, Hong, Cui, Lunbiao, Li, Jingxin, Chen, Yixin, Zhang, Tianying, Ye, Xiangzhong, Li, Changgui, Wu, Ting, Zhang, Jun, Xia, Ning-Shao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135375/ https://www.ncbi.nlm.nih.gov/pubmed/35644168 http://dx.doi.org/10.1016/S2213-2600(22)00131-X

Ejemplares similares

Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
por: Zhu, Fengcai, et al.
Publicado: (2023)

A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2
por: Chen, Junyu, et al.
Publicado: (2022)

Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters
por: Zhang, Liang, et al.
Publicado: (2023)

A review of the safety and efficacy of current COVID-19 vaccines
por: Huang, Zehong, et al.
Publicado: (2022)

Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial
por: Jin, Lairun, et al.
Publicado: (2022)

Protection Duration of COVID-19 Vaccines: Waning Effectiveness and Future Perspective
por: Zhuang, Chunlan, et al.
Publicado: (2022)

Profile of Acute Infectious Markers in Sporadic Hepatitis E
por: Huang, Shoujie, et al.
Publicado: (2010)

Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need
por: Jin, Pengfei, et al.
Publicado: (2021)

Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in China
por: Hu, Yuemei, et al.
Publicado: (2019)

A Cluster of Bunyavirus-Associated Severe Fever With Thrombocytopenia Syndrome Cases in a Coastal Plain Area in China, 2015: Identification of a Previously Unidentified Endemic Region for Severe Fever With Thrombocytopenia Bunyavirus
por: Hu, Jianli, et al.
Publicado: (2019)

Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice
por: Zhang, Li, et al.
Publicado: (2015)

Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial
por: Zhong, Guohua, et al.
Publicado: (2023)

The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis
por: Chen, Qi, et al.
Publicado: (2022)

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
por: Zhang, Yanjun, et al.
Publicado: (2021)

Intranasal administration of dauricine loaded on graphene oxide: multi-target therapy for Alzheimer's disease
por: Wang, Kaixuan, et al.
Publicado: (2021)

Rapid and Sensitive Detection of Salmonella spp. Using CRISPR-Cas13a Combined With Recombinase Polymerase Amplification
por: An, Bailin, et al.
Publicado: (2021)

MiR-195 affects cell migration and cell proliferation by down-regulating DIEXF in Hirschsprung’s Disease
por: Lei, Hao, et al.
Publicado: (2014)

Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial
por: Li, Jingxin, et al.
Publicado: (2022)

Efficacy and safety of intranasal midazolam versus intranasal ketamine as sedative premedication in pediatric patients: a meta-analysis of randomized controlled trials
por: Lang, Bingchen, et al.
Publicado: (2022)

Long-Term immunopersistence and safety of the Escherichia coli-produced HPV-16/18 bivalent vaccine in Chinese adolescent girls
por: Yao, Xingmei, et al.
Publicado: (2022)

Sequential Acquisition of Human Papillomavirus Infection at Genital and Anal Sites, Liuzhou, China
por: Wei, Feixue, et al.
Publicado: (2020)

Advances in the progress of monoclonal antibodies for rabies
por: Fan, Linlin, et al.
Publicado: (2022)

Intranasal Administration of Chitosan Against Influenza A (H7N9) Virus Infection in a Mouse Model
por: Zheng, Mei, et al.
Publicado: (2016)

Antibody Generation and Immunogenicity Analysis of EBV gp42 N-Terminal Region
por: Hong, Junping, et al.
Publicado: (2021)

Protective efficacy of intranasal inactivated pseudorabies vaccine is improved by combination adjuvant in mice
por: Hua, Tao, et al.
Publicado: (2022)

Intranasal delivery of paeoniflorin nanocrystals for brain targeting
por: Wu, Chaoyin, et al.
Publicado: (2020)

A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)
por: Wu, Tao, et al.
Publicado: (2020)

Co-infection with respiratory pathogens among COVID-2019 cases
por: Zhu, Xiaojuan, et al.
Publicado: (2020)

Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis
por: Zhang, Xiaoyin, et al.
Publicado: (2023)

The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors
por: Wang, Guosong, et al.
Publicado: (2023)

Correction: The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors
por: Wang, Guosong, et al.
Publicado: (2023)

CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2
por: Jin, Lairun, et al.
Publicado: (2022)

Rapid detection of human mastadenovirus species B by recombinase polymerase amplification assay
por: Wu, Tao, et al.
Publicado: (2019)

Effect of Intranasal Dexmedetomidine or Midazolam for Premedication on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomy and Adenoidectomy: A Randomized Clinical Trial
por: Shen, Fangming, et al.
Publicado: (2022)

COVID-19 in children: epidemic issues and candidate vaccines
por: Zhang, Peng, et al.
Publicado: (2022)

A comparison of the test-negative and the matched case-control study designs for estimation of EV71 vaccine immunological surrogate endpoints from a randomized controlled trial
por: Zhang, Li, et al.
Publicado: (2022)

Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells
por: Hong, Junping, et al.
Publicado: (2022)

Vaccination with Deglycosylated Modified Hemagglutinin Broadly Protects against Influenza Virus Infection in Mice and Ferrets
por: Zhang, Limin, et al.
Publicado: (2022)

Tumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective
por: Chen, Wuzhen, et al.
Publicado: (2017)

Efficient DNA interrogation of SpCas9 governed by its electrostatic interaction with DNA beyond the PAM and protospacer
por: Zhang, Qian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9j7egsdmkedrnk8srfbvd44hlo